Rothschild Investment Corp IL Grows Position in Vicarious Surgical Inc (NYSE:RBOT)

Rothschild Investment Corp IL boosted its stake in Vicarious Surgical Inc (NYSE:RBOTGet Rating) by 17.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 131,414 shares of the company’s stock after buying an additional 19,669 shares during the quarter. Rothschild Investment Corp IL owned approximately 0.11% of Vicarious Surgical worth $387,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wolverine Asset Management LLC raised its position in Vicarious Surgical by 165.7% in the 1st quarter. Wolverine Asset Management LLC now owns 10,147 shares of the company’s stock valued at $51,000 after buying an additional 6,328 shares during the last quarter. Sciencast Management LP bought a new position in Vicarious Surgical in the 1st quarter valued at $177,000. Northern Trust Corp bought a new position in Vicarious Surgical in the 4th quarter valued at $664,000. Vident Investment Advisory LLC grew its stake in Vicarious Surgical by 2.9% in the 1st quarter. Vident Investment Advisory LLC now owns 1,104,641 shares of the company’s stock valued at $5,589,000 after purchasing an additional 31,325 shares during the period. Finally, NewEdge Wealth LLC bought a new position in Vicarious Surgical in the 1st quarter valued at $141,000. 51.79% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, BTIG Research reduced their price objective on Vicarious Surgical from $8.00 to $7.00 and set a “buy” rating for the company in a research note on Monday, July 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $11.60.

Vicarious Surgical Price Performance

Shares of NYSE:RBOT opened at $3.93 on Wednesday. The company has a market capitalization of $478.35 million, a PE ratio of 19.65 and a beta of 0.75. The business has a fifty day moving average price of $4.03 and a two-hundred day moving average price of $4.16. Vicarious Surgical Inc has a 1 year low of $2.82 and a 1 year high of $15.79.

Vicarious Surgical (NYSE:RBOTGet Rating) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Sell-side analysts anticipate that Vicarious Surgical Inc will post -0.62 earnings per share for the current year.

Insider Transactions at Vicarious Surgical

In other news, Director Philip Liang sold 12,500 shares of the stock in a transaction on Friday, September 16th. The stock was sold at an average price of $3.81, for a total transaction of $47,625.00. Following the completion of the transaction, the director now owns 1,196,577 shares in the company, valued at approximately $4,558,958.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Adam David Sachs sold 11,329 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $3.67, for a total transaction of $41,577.43. Following the sale, the chief executive officer now owns 1,299,590 shares of the company’s stock, valued at approximately $4,769,495.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Philip Liang sold 12,500 shares of the stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $3.81, for a total value of $47,625.00. Following the sale, the director now directly owns 1,196,577 shares in the company, valued at approximately $4,558,958.37. The disclosure for this sale can be found here. In the last 90 days, insiders sold 119,272 shares of company stock worth $466,235. 52.48% of the stock is owned by company insiders.

Vicarious Surgical Profile

(Get Rating)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Read More

Want to see what other hedge funds are holding RBOT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vicarious Surgical Inc (NYSE:RBOTGet Rating).

Institutional Ownership by Quarter for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.